Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose To review the current literature on reported pulmonary, liver, and nerve adverse reactions (ARs) of long-term Nitrofurantoin (NF) suppression in older patients treated for urinary tract infections (UTIs). Materials and methods An extensive literature search was performed on PubMed for the search terms “Nitrofurantoin,” and “Nitrofurantoin and lung, pulmonary, liver, nerve or ARs”. Relevant cited papers were also analyzed. Articles not in English, or related to children, or pregnant women were excluded. Results In 43 articles and other texts meeting the inclusion criteria from 1968 to 2014, rates of long-term NF-related pulmonary ARs compared to total NF prescriptions differed worldwide, but remained extremely small at 0.001% (USA) and 0.001% for pulmonary and hepatic ARs (France). Among all NF ARs, rates of pulmonary ARs differed across the literature from 2% (UK), 3% (Holland), 5% (Sweden), to 7% (Australia). Nerve ARs were reported as .0007% and liver ARs as .0003% of total prescriptions Conclusions Pulmonary, nerve, or liver ARs resulting from long-term NF prophylaxis in older patients treated for UTIs are potentially serious but extremely rare, and should not deter from the cautious use of NF in this population.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalUrological Science
Volume27
Issue number4
DOIs
StatePublished - Dec 1 2016

Fingerprint

Nitrofurantoin
Urinary Tract
Lung
Liver
Urinary Tract Infections
Prescriptions
PubMed
Sweden
Netherlands
France
Pregnant Women

Keywords

  • nitrofurantoin
  • older patients
  • urinary tract infections
  • urinary tract prophylaxis

ASJC Scopus subject areas

  • Urology

Cite this

Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient. / Rego, Lauren L.; Glazer, Craig S.; Zimmern, Philippe E.

In: Urological Science, Vol. 27, No. 4, 01.12.2016, p. 193-198.

Research output: Contribution to journalReview article

@article{0fac87f221744ce8bd836394e5762d10,
title = "Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient",
abstract = "Purpose To review the current literature on reported pulmonary, liver, and nerve adverse reactions (ARs) of long-term Nitrofurantoin (NF) suppression in older patients treated for urinary tract infections (UTIs). Materials and methods An extensive literature search was performed on PubMed for the search terms “Nitrofurantoin,” and “Nitrofurantoin and lung, pulmonary, liver, nerve or ARs”. Relevant cited papers were also analyzed. Articles not in English, or related to children, or pregnant women were excluded. Results In 43 articles and other texts meeting the inclusion criteria from 1968 to 2014, rates of long-term NF-related pulmonary ARs compared to total NF prescriptions differed worldwide, but remained extremely small at 0.001{\%} (USA) and 0.001{\%} for pulmonary and hepatic ARs (France). Among all NF ARs, rates of pulmonary ARs differed across the literature from 2{\%} (UK), 3{\%} (Holland), 5{\%} (Sweden), to 7{\%} (Australia). Nerve ARs were reported as .0007{\%} and liver ARs as .0003{\%} of total prescriptions Conclusions Pulmonary, nerve, or liver ARs resulting from long-term NF prophylaxis in older patients treated for UTIs are potentially serious but extremely rare, and should not deter from the cautious use of NF in this population.",
keywords = "nitrofurantoin, older patients, urinary tract infections, urinary tract prophylaxis",
author = "Rego, {Lauren L.} and Glazer, {Craig S.} and Zimmern, {Philippe E.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.urols.2016.07.004",
language = "English (US)",
volume = "27",
pages = "193--198",
journal = "Urological Science",
issn = "1879-5226",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient

AU - Rego, Lauren L.

AU - Glazer, Craig S.

AU - Zimmern, Philippe E.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Purpose To review the current literature on reported pulmonary, liver, and nerve adverse reactions (ARs) of long-term Nitrofurantoin (NF) suppression in older patients treated for urinary tract infections (UTIs). Materials and methods An extensive literature search was performed on PubMed for the search terms “Nitrofurantoin,” and “Nitrofurantoin and lung, pulmonary, liver, nerve or ARs”. Relevant cited papers were also analyzed. Articles not in English, or related to children, or pregnant women were excluded. Results In 43 articles and other texts meeting the inclusion criteria from 1968 to 2014, rates of long-term NF-related pulmonary ARs compared to total NF prescriptions differed worldwide, but remained extremely small at 0.001% (USA) and 0.001% for pulmonary and hepatic ARs (France). Among all NF ARs, rates of pulmonary ARs differed across the literature from 2% (UK), 3% (Holland), 5% (Sweden), to 7% (Australia). Nerve ARs were reported as .0007% and liver ARs as .0003% of total prescriptions Conclusions Pulmonary, nerve, or liver ARs resulting from long-term NF prophylaxis in older patients treated for UTIs are potentially serious but extremely rare, and should not deter from the cautious use of NF in this population.

AB - Purpose To review the current literature on reported pulmonary, liver, and nerve adverse reactions (ARs) of long-term Nitrofurantoin (NF) suppression in older patients treated for urinary tract infections (UTIs). Materials and methods An extensive literature search was performed on PubMed for the search terms “Nitrofurantoin,” and “Nitrofurantoin and lung, pulmonary, liver, nerve or ARs”. Relevant cited papers were also analyzed. Articles not in English, or related to children, or pregnant women were excluded. Results In 43 articles and other texts meeting the inclusion criteria from 1968 to 2014, rates of long-term NF-related pulmonary ARs compared to total NF prescriptions differed worldwide, but remained extremely small at 0.001% (USA) and 0.001% for pulmonary and hepatic ARs (France). Among all NF ARs, rates of pulmonary ARs differed across the literature from 2% (UK), 3% (Holland), 5% (Sweden), to 7% (Australia). Nerve ARs were reported as .0007% and liver ARs as .0003% of total prescriptions Conclusions Pulmonary, nerve, or liver ARs resulting from long-term NF prophylaxis in older patients treated for UTIs are potentially serious but extremely rare, and should not deter from the cautious use of NF in this population.

KW - nitrofurantoin

KW - older patients

KW - urinary tract infections

KW - urinary tract prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=85007163729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007163729&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2016.07.004

DO - 10.1016/j.urols.2016.07.004

M3 - Review article

AN - SCOPUS:85007163729

VL - 27

SP - 193

EP - 198

JO - Urological Science

JF - Urological Science

SN - 1879-5226

IS - 4

ER -